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Abstract
The first decade of genome sequencing stimulated an explosion in the charac-
terization of unknown proteins. More recently, the pace of functional discovery
has slowed, leaving around 20% of the proteins even in well-studied model or-
ganisms without informative descriptions of their biological roles. Remarkably,
many uncharacterized proteins are conserved from yeasts to human, suggesting
that they contribute to fundamental biological processes. To fully understand
biological systems in health and disease, we need to account for every part of
the system. Unstudied proteins thus represent a collective blind spot that limits
the progress of both basic and applied biosciences.
We use a simple yet powerful metric based on Gene Ontology (GO) bio-
logical process terms to define characterized and uncharacterized proteins for
human, budding yeast, and fission yeast. We then identify a set of conserved
but unstudied proteins in S. pombe, and classify them based on a combination
of orthogonal attributes determined by large-scale experimental and compara-
tive methods. Finally, we explore possible reasons why these proteins remain
neglected, and propose courses of action to raise their profile and thereby reap
the benefits of completing the catalog of proteins’ biological roles.
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Slow progress in characterizing unknowns
When the first eukaryotic chromosome (chromosome III of Saccharomyces cere-
visiae) was sequenced in 1992, the most surprising discovery was that previously
undetected protein-coding genes outnumbered mapped genes by a factor of five
[1, 2]. Researchers had generally assumed that few proteins remained to be
discovered, especially in an organism as intensively studied as yeast. The com-
pletion of the S. cerevisiae genome sequence in 1996 confirmed that more than
half the genes lacked any indication of their biochemical activity or broader bio-
logical role [2]. Over the ensuing two decades, complete genome sequences have
become available for over 6500 eukaryotic species [3]. At first, characterization
of newly discovered genes progressed rapidly in model species, as researchers
supplemented classical biochemistry and forward genetics with reverse genet-
ics, homology modeling, and large-scale systematic techniques to study novel
genes. Complete genome sequences also allowed the deployment of large-scale
systematic techniques [4]. More recently, however, progress has slowed, even in
well-studied species such as the budding yeast S. cerevisiae and the fission yeast
Schizosaccharomyces pombe.
Fig 1 shows protein characterization over the past 28 years for these two
yeasts. Notably, the proportions characterized in fission yeast (84%) and bud-
ding yeast (82%) have only slightly increased in the past decade (from 80%, as
noted by Pen˜a-Castillo and Hughes [5], and 77% respectively). Across all stud-
ied eukaryotic species, the proportion of characterized proteins has reached a
plateau around 80%, and exhibits a long-tailed distribution, with the biological
roles of the remaining 20% still elusive.
Here we use a simple yet powerful metric based on Gene Ontology (GO)
biological process terms to define characterized and uncharacterized proteins
for human and the two model yeasts. We then combine our GO-based classi-
fication with information about taxonomic conservation using fission yeast to
identify a set of broadly conserved, but unstudied, proteins. We classify the
fission yeast conserved but unstudied protein set based on a combination of
orthogonal attributes (e.g. taxonomic conservation, mutant viability, protein
sequence features, localization). Finally, we explore possible reasons why these
proteins remain neglected, propose courses of action to raise their profile among
bench researchers and bioinformaticians, and posit the benefits of completing
catalog of proteins’ biological roles.
Defining unknown metrics: what counts as “known”?
To estimate more precisely the proportion of a proteome that is characterized,
and to provide inventories of uncharacterized gene products, the “known” cat-
egory must be rigorously defined. However, the gradual accumulation of data
of many different types, from diverse experimental and computational methods
and multiple sources, makes it challenging to draw a clear line between “known”
and “unknown”. For example, in 2004 Hughes et al. [6] observed that the then-
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current Yeast Proteome Database (YPD) listed 80% of S. cerevisiae genes as
“known”, but also noted that by more stringent criteria based on Gene Ontology
(GO) annotation then in the Saccharomyces Genome Database (SGD), 30–40%
remained unknown and others only poorly understood. Knowledge acquisition
is necessarily a continuum — different experiments are performed at different
scales (e.g. high- versus low-throughput) and yield results at different levels of
biological detail (e.g. detecting DNA repair versus distinguishing mismatch re-
pair from base excision repair) and confidence (stemming from variation in the
quality of assays and the number of replicates performed). For these reasons, the
characterization status of gene products does not fall on a simple linear scale.
Biologists often make qualitative judgment calls to designate individual gene
products as “novel”, “barely characterized”, or “relatively well-characterized”.
While this serves the purposes of individual researchers working on a gene-by-
gene basis, a more quantitative and objective approach is required to summarize
the status of functional characterization for an entire proteome, and to facilitate
cross-species comparisons.
Metrics to describe functional characterization levels
To develop workable metrics for the status of the functional annotation of a given
proteome, we have exploited GO annotation [7], and illustrate this scheme using
the proteomes of S. cerevisiae, S. pombe, and human as examples. Since the
functional attributes of gene products of diverse species are routinely described
using GO, these metrics are widely applicable.
The GO Molecular Function (MF) ontology describes molecular-level activ-
ities of gene products (such as catalytic, transporter, and receptor activities).
GO Biological Processes (BP) refers to ordered assemblies of molecular functions
representing physiological roles of gene products (e.g. involvement in cytokinesis
or DNA replication). GO Cellular Component (CC) provides the locations of
gene products (organelles, complexes, etc.). Determining each annotation type
relies on different experimental techniques, yielding complementary results and
insights. We might know a gene product’s molecular function (MF) but not the
physiological context in which that product is involved (BP). As an example,
knowing that a protein is a kinase (MF) is not very informative until we find
that a deletion mutant of the gene encoding that protein is defective in meiotic
nuclear division (BP) and the protein itself localizes to chromatin (CC).
Annotation coverage for proteins by Gene Ontology aspect
One simple way to quantify the degree to which the function of a given gene
product has been characterized is to report annotation to one, two, or all three
GO aspects (MF, BP, CC). GO aspect coverage provides a simple metric that
is accessible for any species by counting gene products with (or without) an-
notation to each aspect. Fig 2 shows coverage by ontology aspect for human,
fission yeast, and budding yeast proteins. From this viewpoint, we can quickly
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assess the number of gene products annotated to all three aspects of GO (usu-
ally well-characterized), or none at all (uncharacterized), and assess what types
are absent for a species.
Known physiological function: GO slim process coverage
Although informative, the activities captured by MF and the localizations de-
scribed by CC make only a limited contribution to knowledge about a gene
product’s characterization if taken in isolation. In contrast, the physiological
context provided by biological process annotation reveals more about the role of
a gene product in an organism’s biology and therefore provides a useful bench-
mark for preliminary characterization.
To use this information as a measure of the progress in a protein’s func-
tional characterization, we use the annotation overviews provided by tailored
GO term subsets known as “GO slims” [8]. We created a biological process slim
set covering as many annotated gene products as possible, while remaining in-
formative about the physiological context in which they operate. As our starting
point, we took the fission yeast GO biological process slim developed at Pom-
Base over 8 years [9], which provides excellent coverage of informative cellular
processes for fission yeast (99.4% of annotated proteins with a known process),
and minimizes overlap between terms. The PomBase slim aims to demonstrate
the distribution of processes within distinct “modules” of biology (cytokinesis,
tRNA metabolism, DNA replication etc.) [10, 11], and therefore excludes overly
general biological process terms, such as “metabolism” or “cellular component
organization”, that would increase coverage at the expense of specific context.
Terms that recapitulate activities in the MF ontology (e.g. “protein phosphory-
lation”) or describe phenotypic observations but do not correspond to a specific
physiological role for a gene product (e.g. “response to chemical”) are also ex-
cluded. We then extended the 53-term PomBase slim into a generalized process
slim of 115 terms to use in cross-species analysis, as summarized in Fig 3A.
For any annotation-based metric, it is important to distinguish unknown
(or unstudied) from unannotated gene products. Here, unknown gene products
are defined as those that have been evaluated by curators and have no anno-
tation to any BP slim terms (these gene products are annotated to the root
term “biological process” with the evidence code “no data (ND)”). Unanno-
tated are those not explicitly indicated as unknown but which, nevertheless,
have no annotation from experiment or inference. Because all fission yeast and
budding yeast genes have been systematically assessed using all available data,
any gene products lacking specific GO annotations can confidently be deemed
to have unknown biological roles. For the human proteome, manual inspection
of the unannotated proteins revealed that many can actually be annotated to a
biological process based on experimental data in the literature or by homology-
based inference, and thus classified as characterized. To make this knowledge
available, we manually curated 1235 GO annotations for 598 human proteins
from 348 publications, including biological process assignments for 266 previ-
ously unannotated proteins. These annotations will be submitted to the GO
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Consortium for inclusion in the human GO annotation dataset. Fig 3B shows
the proportions of the S. pombe, S. cerevisiae, and human proteomes that are
known (i.e. annotated to informative biological process terms), unannotated,
annotable, or unknown. See Supplementary Data for GO slim term IDs (Table
S1), input protein lists (Tables S2–S4), GO slim outputs (Tables S5–S7), and
unknown gene lists (Tables S8–S10).
Why do these proteins remain unstudied?
Our GO slim-based characterization metric confirms the impression from sim-
pler metrics that, for the two model yeasts and human, about 20% of proteins
lack physiologically informative descriptions. Why do so many proteins, many
of them conserved, remain unstudied? Below, we consider biological and socio-
logical/cultural factors that contribute to the apparent lack of interest in these
unknown proteins.
Biological bias
One factor influencing gene characterization is simply how easily one gene’s con-
tribution to an organism can be detected. Deletion mutants of essential genes
have a clear phenotype that indicates an important function — for yeasts, the
failure to grow on rich media. As a consequence, these genes, and the core
processes in which they participate, are well characterized. For example, only
24 of the genes in the fission yeast unknown set are essential in rich media.
Changes in cell morphology are also readily identifiable phenotypes. Visual
screening and analysis of the fission yeast genome-wide deletion collection for
morphology phenotypes under standard laboratory conditions found obvious
abnormalities for only 10% of 643 genes of unknown function [12]. The most
commonly used experimental conditions, designed as they are to maximize cell
growth, can hide environment-dependent roles. Many more of the 676 currently
uncharacterized (per Figure 3B) fission yeast genes are associated with growth or
viability phenotypes upon specific chemical challenges (26.1%) than under stan-
dard laboratory conditions (3.6%) (PomBase [10, 11], queries run 11/11/2018).
In budding yeast, only 34% of all deletion mutants display a growth phenotype
under standard laboratory conditions, whereas 97% of all genes are essential for
optimal growth in at least one condition when assayed under multiple chemical
or environmental perturbations [13].
Protein characterization has traditionally emphasized core biological pro-
cesses over those that reflect interactions with the environment. However, anal-
ysis of the proteins that have recently (2016–2018) been removed from the fission
yeast “conserved unknown” set because their functions have been determined re-
veals that they most often participate in environment-responsive processes such
as signalling, detoxification, proteostasis, lipostasis and mitochondrial organi-
zation (Table 1). Many of these functions are associated with the age-related
accumulation of damaged or misfolded proteins, which become debilitating over
5
.CC-BY 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/469569doi: bioRxiv preprint first posted online Nov. 16, 2018; 
time. In humans, such functions are implicated in neurodegenerative diseases,
such as Alzheimer’s and motor neuron diseases [14], which underscores the im-
portance of making strenuous efforts to elucidate the functions of the remaining
“conserved unknowns”. It should also be pointed out that the ecology of yeasts
is poorly understood, and we postulate that many unknown proteins function
in aspects of life that are not normally probed in the laboratory (e.g., interac-
tions with pathogens, or survival within insect vectors). We anticipate that a
greater variety of experimental conditions will supply more information about
the unknown gene products catalogued here to reveal the roles of many gene
products in processes fundamental for human health.
Research bias
In fission yeast, the majority of new knowledge over the past decade provides
increasing detail for previously described proteins. This bias towards studying
already-known proteins is not peculiar to yeast research. In their essay “Too
many roads not taken” [15], Edwards et al. observe that 70% of human protein
research still focuses on the 10% of proteins known before the human genome
was sequenced. Although few studies have explored the causes of the observed
emphasis on known proteins, we can identify a number of plausible contributing
factors, which are largely borne out by a recent large-scale analysis of publica-
tions on human genes [16]. First, the complexity of biology demands that in-
vestigators narrow their study targets to a manageable range. Researchers with
established interests in specific topics thus naturally focus their work where they
have deep knowledge, and extend their studies to novel genes only if a strong
lead emerges, for instance, from work in another species or from a data-mining
approach that implicates them in biological processes already under investiga-
tion. Indeed, Stoeger et al. find that research in model organisms strongly
influences the initial study of individual human genes. Both papers also high-
light pragmatic considerations, notably the availability of research tools, and
socio-political factors including career timelines, funding priorities, and peer
review, all of which exacerbate the tendency to avoid the wholly unknown.
Risk-averse funders and reviewers tend not to favor long-range strategies aimed
at genes without an existing functional context for fear of diverting resources
towards targets whose significance is not guaranteed. Without a shift in per-
spective, proteins without any existing functional annotation will continue to be
neglected, to the detriment of basic and applied biomedical research. Stoeger
et al. note that current research is not only slow to cover novel genes, but also
“can significantly deviate from the actual biological importance of individual
genes”.
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Classifying the conserved unknown proteins, or:
What lies undiscovered?
The stubborn core of remaining proteins of unknown function are often dis-
missed as species-specific, but we have often found otherwise, and we can no
longer afford to sweep these proteins under the carpet. Therefore, to provide
further insight into why some gene products elude physiological characteriza-
tion, we present a case study using the set of 410 fission yeast proteins of un-
known physiological role that have orthologs outside the Schizosaccharomyces
clade (the “conserved unknowns”). We classify these 410 proteins according to
a range of orthogonal biological attributes (including taxonomic conservation,
identification of a catalytic fold or domain, cellular localization, viability). Fig 4
presents the subset of 200 proteins in this group which are conserved outside
fungi (in vertebrates, archaea, or bacteria; details for the full set of 410 proteins
are provided in Supplementary Figure S1 and Table S11). The number of con-
served unknown proteins that play an essential role under permissive growth
conditions is disproportionally low (4.4%; 18/410), and almost half of these 18
essential proteins are localized to the mitochondria or the endoplasmic reticu-
lum. Only 8 essential genes are conserved in vertebrates (all are organellar),
and only a single protein out of 53 conserved between yeast and prokaryotes
(but not vertebrates) is essential. A substantial proportion of the 200 pro-
teins conserved outside the fungi (76) are absent from Saccharomyces due to
the well-documented lineage-specific gene losses in its evolutionary history [17];
characterized gene products with this taxonomic distribution are most highly
enriched for chromatin organization and mRNA metabolism. Unknown mito-
chondrial and endomembrane system proteins are enriched for proteins with
transmembrane domains (59/114). Unknown nuclear proteins are predicted to
include more transferases than other enzymatic activities; the set of nuclear pro-
teins shared only with eukaryotes includes 19 non-catalytic domains of unknown
function (DUFs) and 12 protein-protein interaction domains (e.g. WD, ankyrin,
or TPR) that frequently function as scaffolds for protein complexes [18]. This
multi-factorial classification can support the prediction of likely physiological
roles that can be experimentally tested.
Strategies to link unknown genes to broad cellular
roles
Despite almost a century of gene product-specific biochemical and genetic inter-
rogation, and two decades of post-genomic research, a large number of proteins
conserved from yeast to human still have no known biological role. Broadly con-
served unknown eukaryotic proteins can be assumed to have important cellular
roles conserved over 500 million years of evolution. It is, therefore, remarkable
that this gene set has hardly reduced over the past decade. In this period,
familiar genes have been studied in ever-greater depth, presumably at the ex-
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pense of the characterization of genes of hitherto unknown function (e.g. over
33,000 papers with “p53” in title have been published since 2007). Assuming
a diminishing return for studies on highly characterized proteins, investigations
on unstudied proteins will have a relatively higher impact that is likely to out-
weigh the considerable initial efforts required to place them within the context
of current knowledge.
To jump-start renewed progress in unknown gene characterization, two ma-
jor stumbling blocks must be overcome: One is to identify the cohort of genes of
unknown function, and the other is to develop mechanisms to bring the proteins
that they encode to the attention of interested researchers. Here, we provide
a framework that uses a generally accessible set of criteria based on manually
curated data to identify and classify unstudied proteins, which could easily be
extended with additional criteria for further annotation specificity in future it-
erations. The construction of inventories of unknown proteins will ultimately
depend on accurate and complete functional annotation of all genes of the major
model species.
Commentators on genome-scale research have long recognized that, in order
to fully describe an organism’s protein complement, it will be necessary to de-
ploy parallel experimental and computational methods, at both large and small
scales [4, 6]. Understanding how investigatory biases and the characteristics of
particular gene sets have converged to prevent characterization will help us to
identify the most promising routes to uncovering unknown functions. These,
and other factors that contribute to the neglect of the characterization of con-
served gene products that are likely to have novel biological roles, deserve further
in-depth consideration. It is likely that, to fill the persistent knowledge gaps rep-
resented by the roughly 20% of proteins that remain uncharacterized, a creative
combination of existing and emerging experimental and in silico methods will
be required, as well as an increased awareness among the scientific community
of the value of a full proteome description. Because basic knowledge at the cel-
lular level provides the building blocks of translational research, drug discovery,
personalized medicine, metabolomics, and systems biology, comprehensive pro-
teome characterization underpins the success of numerous and diverse endeavors
across all of the biological and medical sciences.
Supplementary materials
• Figure S1. Taxonomic conservation and features of unknown proteins.
Classification of 410 conserved unknown fission yeast proteins (PomBase
manual taxonomic conservation assignments, queried on 31/07/2018) along
various axes. Proteins were classed as catalytic or non-catalytic based
on protein domain, fold, clan or superfamily membership, using InterPro
[18] and GO [7] assignments. Cellular locations using GO annotation are
available for most of the unknown proteome based on a genome-wide lo-
calization study and inference from other models [19]. Viability data come
from large-scale screens reported by Kim et al. [20] and Chen et al. [21].
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• Table S1. GO IDs for biological process GO slim set used in Figure 4
analysis.
• Table S2. S. pombe proteins used in Figure 4 analysis (PomBase system-
atic IDs).
• Table S3. S. cerevisiae proteins used in Figure 4 analysis (SGD ORF
names and UniProtKB accessions).
• Table S4. Human proteins used in Figure 4 analysis (UniProtKB acces-
sions).
• Table S5. S. pombe GO slim results from Figure 4 analysis.
• Table S6. S. cerevisiae GO slim results from Figure 4 analysis.
• Table S7. Human GO slim results from Figure 4 analysis.
• Table S8. Unknown S. pombe proteins from Figure 4 analysis.
• Table S9. Unknown S. cerevisiae proteins from Figure 4 analysis.
• Table S10. Unknown and unannotated human proteins from Figure 4
analysis. A, proteins that had no GO biological process annotation when
analyzed, but can be annotated based on available literature. B, proteins
remaining unknown following analysis (annotated to the GO biological
process root, or lacking both annotation and data that would support
annotation).
• Table S11. List of genes classified in Figure S1.
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Figure 1: Characterization history of budding yeast and fission yeast proteins.
Numbers of S. pombe and S. cerevisiae proteins that have had their biological
roles either determined from experiments or inferred from sequence orthology
to known proteins in other species, plotted as a function of time. The numbers
of unknown proteins have not markedly decreased over the past 15 years. Data
sources: S. cerevisiae 1994–1998 [22], 2000 [23]), 2002[24], 2009 [25], 2013 [26],
2018 this study (see Figure 3); S. pombe [27].
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Process Proteins
Membrane biology
lipid metabolism 15
transmembrane transport 9
vesicle-mediated transport 9
organelle localization by membrane tethering 4
othter membrane organization 3
other ER processes 2
42
Communication
signaling 9
transcription 6
chromatin organization 1
16
Catabolism and detoxification
detoxification 25
protein catabolism 5
apoptotic process 4
DNA repair 3
nucleobase-containing compound catabolism 5
autophagy 1
mannose catabolism 1
44
Mitochondrial processes and energy
mitochondrial gene expression 4
mitochondrial organization 3
energy generation 4
11
Other processes
tRNA metabolism (cytosolic) 3
ribosome biogenesis (cytosolic) 5
mRNA metabolism 2
cytoplasmic translation 2
cytoskeleton organization 3
protein folding (cytosolic) 1
protein complex assembly 1
nucleocytoplasmic transport 1
chromosome segregation 1
amino acid metabolism 2
cofactor metabolism 1
other 5
27
TOTAL 140
Table 1: GO slim classification of conserved S. pombe proteins characterized
between 2016 and 2018.
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Figure 2: GO aspect coverage of budding yeast, fission yeast, and human pro-
teins. Venn diagrams indicate the number of protein coding gene products an-
notated to each Gene Ontology aspect (Biological Process, Molecular Function,
Cellular Component). Data sources: S. pombe, PomBase 25 September 2018;
S. cerevisiae, YeastMine [28] 25 September 2018; human, HumanMine [29] and
GO repository [30], both 26 September 2018.
15
.CC-BY 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/469569doi: bioRxiv preprint first posted online Nov. 16, 2018; 
F
ig
u
re
3:
G
O
sl
im
an
al
y
si
s
of
b
u
d
d
in
g
ye
as
t,
fi
ss
io
n
ye
as
t,
an
d
h
u
m
an
p
ro
te
in
s.
A
:
G
en
er
ic
G
O
b
io
lo
gi
ca
l
p
ro
ce
ss
sl
im
se
t
cr
ea
ti
on
fl
ow
ch
ar
t.
T
h
e
fi
ss
io
n
ye
as
t
G
O
b
io
lo
gi
ca
l
p
ro
ce
ss
sl
im
[9
]
w
as
ap
p
li
ed
to
h
u
m
an
an
d
S
.
ce
re
vi
si
a
e
p
ro
te
in
se
ts
,
an
d
th
en
it
er
at
iv
el
y
ex
te
n
d
ed
to
im
p
ro
ve
co
ve
ra
ge
b
y
ad
d
in
g
te
rm
s.
S
om
e
p
ro
ce
ss
es
w
er
e
sw
ap
p
ed
(e
.g
.
“c
y
to
p
la
sm
ic
tr
an
sl
at
io
n
”
in
th
e
fi
ss
io
n
y
ea
st
sl
im
fo
r
m
or
e
ge
n
er
al
“t
ra
n
sl
at
io
n
”)
to
ac
co
m
m
o
d
at
e
th
e
le
ss
sp
ec
ifi
c
an
n
ot
at
io
n
av
ai
la
b
le
in
ot
h
er
sp
ec
ie
s.
O
v
er
ly
b
ro
ad
te
rm
s
(e
.g
.
“m
et
ab
ol
is
m
”)
a
n
d
te
rm
s
re
p
re
se
n
ti
n
g
ac
ti
v
it
ie
s
(m
ol
ec
u
la
r
fu
n
ct
io
n
s)
in
th
e
b
io
lo
gi
ca
l
p
ro
ce
ss
on
to
lo
gy
(e
.g
.
“p
h
os
p
h
or
y
la
ti
on
”)
w
er
e
ex
cl
u
d
ed
fr
om
th
e
ge
n
er
ic
sl
im
se
t.
A
t
co
n
ve
rg
en
ce
(t
h
e
p
oi
n
t
w
h
er
e
n
o
ad
d
it
io
n
al
in
fo
rm
at
iv
e
te
rm
s
co
u
ld
b
e
id
en
ti
fi
ed
fo
r
ge
n
e
p
ro
d
u
ct
s
w
it
h
b
io
lo
gi
ca
l
p
ro
ce
ss
an
n
ot
at
io
n
s)
,
p
ro
te
in
s
an
n
ot
at
ed
to
sl
im
te
rm
s
w
er
e
cl
as
si
fi
ed
as
“k
n
ow
n
”
(4
3
93
S
.
po
m
be
;
49
36
S
.
ce
re
vi
si
a
e
;
16
35
4
h
u
m
an
).
T
h
e
re
m
ai
n
in
g
p
ro
te
in
s
w
it
h
u
n
in
fo
rm
at
iv
e
p
ro
ce
ss
es
w
er
e
cl
as
si
fi
ed
as
u
n
k
n
ow
n
,
al
on
g
w
it
h
th
o
se
al
re
ad
y
id
en
ti
fi
ed
as
u
n
k
n
ow
n
b
y
an
n
ot
at
io
n
to
th
e
ro
ot
n
o
d
e
w
it
h
ev
id
en
ce
co
d
e
N
D
(N
o
D
at
a)
.
M
an
u
al
as
se
ss
m
en
t
o
f
th
e
re
m
ai
n
in
g
h
u
m
an
p
ro
te
in
s
w
it
h
n
o
G
O
b
io
lo
gi
ca
l
p
ro
ce
ss
an
n
ot
at
io
n
ad
d
ed
26
6
p
ro
te
in
s,
b
ri
n
gi
n
g
th
e
“k
n
ow
n
”
to
ta
l
to
16
62
0.
F
in
al
“u
n
k
n
ow
n
”
p
ro
te
in
to
ta
ls
ar
e
67
6
in
S
.
po
m
be
,
97
8
in
S
.
ce
re
vi
si
a
e,
an
d
31
17
in
h
u
m
an
.
T
h
e
se
t
o
f
G
O
sl
im
te
rm
s
is
av
ai
la
b
le
in
S
u
p
p
le
m
en
ta
ry
ta
b
le
S
1.
(C
on
ti
n
u
ed
on
n
ex
t
p
ag
e.
)
16
.CC-BY 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/469569doi: bioRxiv preprint first posted online Nov. 16, 2018; 
Figure 3: (Continued from preceding page.) B: Proportions of proteins with
known GO slim biological role. For all three species, “known” proteins have
annotation to at least one term from the GO slim set (see A), and “unknown”
proteins do not. Because the human proteome includes some proteins that lack
annotation in the GO database, the proportions of unannotated proteins that we
found to be known (i.e. annotatable) and unknown are indicated separately. All
protein datasets exclude dubious proteins and transposons. Analysis was per-
formed using GOTermFinder [31], with GO data from 25/09/2018 and the GO
slim created as described in A. Input protein lists are available in Supplemen-
tary tables S2 (S. pombe), S3 (S. cerevisiae), and S4 (human). GOTermFinder
output is available in Supplementary tables S5 (S. pombe), S6 (S. cerevisiae),
and S7 (human).
17
.CC-BY 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/469569doi: bioRxiv preprint first posted online Nov. 16, 2018; 
F
ig
u
re
4
:
T
ax
on
om
ic
co
n
se
rv
at
io
n
a
n
d
fe
at
u
re
s
of
u
n
k
n
ow
n
p
ro
te
in
s.
C
la
ss
ifi
ca
ti
on
of
21
0
co
n
se
rv
ed
u
n
k
n
ow
n
fi
ss
io
n
ye
as
t
p
ro
te
in
s
al
on
g
va
ri
ou
s
ax
es
.
P
o
m
B
a
se
cu
ra
to
rs
m
an
u
al
ly
as
si
gn
p
ro
te
in
-c
o
d
in
g
ge
n
es
to
on
e
of
a
se
t
of
b
ro
ad
ta
x
on
om
ic
cl
as
si
fi
er
s
[1
1,
32
].
P
o
m
B
as
e
al
so
m
ai
n
ta
in
s
m
an
u
al
ly
cu
ra
te
d
li
st
s
of
or
th
ol
og
s
b
et
w
ee
n
S
.
po
m
be
an
d
S
.
ce
re
vi
si
a
e,
an
d
b
et
w
ee
n
S
.
po
m
be
an
d
h
u
m
an
,
th
re
e
eu
ka
ry
ot
ic
sp
ec
ie
s
se
p
ar
at
ed
b
y
ca
.
50
0–
10
00
m
il
li
on
ye
ar
s
of
ev
ol
u
ti
on
.
In
co
m
b
in
at
io
n
,
th
es
e
in
ve
n
to
ri
es
ca
n
b
e
u
se
d
to
id
en
ti
fy
co
n
se
rv
at
io
n
ac
ro
ss
ta
x
on
om
ic
sp
ac
e
at
d
iff
er
en
t
le
ve
ls
of
sp
ec
ifi
ci
ty
.
O
f
th
e
fi
ss
io
n
ye
as
t
“u
n
k
n
ow
n
”
p
ro
te
in
-c
o
d
in
g
ge
n
es
,
41
0
ar
e
co
n
se
rv
ed
ou
ts
id
e
th
e
S
ch
iz
o
sa
cc
h
a
ro
m
yc
es
cl
ad
e.
O
f
th
es
e,
21
0
ar
e
p
re
se
n
t
ei
th
er
in
fu
n
gi
a
n
d
v
er
te
b
ra
te
s,
or
in
fu
n
g
i
a
n
d
p
ro
ka
ry
ot
es
(d
at
a
fr
om
P
om
B
as
e
m
an
u
al
as
si
gn
m
en
ts
,
q
u
er
ie
d
on
31
/0
7/
20
18
).
P
ro
te
in
s
w
er
e
cl
as
se
d
a
s
ca
ta
ly
ti
c
o
r
n
o
n
-c
at
al
y
ti
c
b
as
ed
on
p
ro
te
in
d
om
ai
n
,
fo
ld
,
cl
an
or
su
p
er
fa
m
il
y
m
em
b
er
sh
ip
,
u
si
n
g
In
te
rP
ro
[1
8
]
an
d
G
O
[7
]
as
si
g
n
m
en
ts
.
C
el
lu
la
r
lo
ca
ti
on
s
u
si
n
g
G
O
an
n
ot
at
io
n
ar
e
av
ai
la
b
le
fo
r
m
os
t
of
th
e
u
n
k
n
ow
n
p
ro
te
om
e
b
as
ed
on
a
ge
n
om
e-
w
id
e
lo
ca
li
za
ti
on
st
u
d
y
an
d
in
fe
re
n
ce
fr
om
ot
h
er
m
o
d
el
s
[1
9]
.
V
ia
b
il
it
y
d
at
a
co
m
e
fr
om
la
rg
e-
sc
al
e
sc
re
en
s
re
p
or
te
d
b
y
K
im
et
a
l.
[2
0]
a
n
d
C
h
en
et
a
l.
[2
1]
.
T
h
e
fi
ss
io
n
ye
as
t
“c
on
se
rv
ed
u
n
k
n
ow
n
”
p
ro
te
in
se
t
[3
3]
is
re
v
ie
w
ed
co
n
ti
n
u
al
ly
fo
r
n
ew
fu
n
ct
io
n
al
d
at
a.
18
.CC-BY 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/469569doi: bioRxiv preprint first posted online Nov. 16, 2018; 
